Marimed (MRMD) Share-based Compensation (2011 - 2026)
Marimed (MRMD) posted quarterly Share-based Compensation of $325000.0 for Q1 2026, down 40.59% year-over-year from $547000.0 in Q1 2025, and down 22.99% quarter-over-quarter from $422000.0 in Q4 2025.
Marimed (MRMD) Share-based Compensation (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Share-based Compensation for 13 consecutive years, with $325000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 40.59% year-over-year to $325000.0; the TTM figure through Mar 2026 stood at $1.7 million (up 436.1% YoY), while the FY2025 annual figure was $1.9 million, up 18900.0% from the prior year.
- Share-based Compensation slipped to $325000.0 in Q1 2026 per MRMD's latest filing, from $422000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.2 million in Q2 2023 and bottomed at -$4.3 million in Q4 2023.
- Historically, Share-based Compensation has averaged $602500.0 across 5 years, with a median of $353500.0 in 2025.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 8136.67% — and 2023, when it sank 7393.1%.
- Marimed's Share-based Compensation stood at -$58000.0 in 2022, then tumbled by 7393.1% to -$4.3 million in 2023, then soared by 82.47% to -$762000.0 in 2024, then soared by 155.38% to $422000.0 in 2025, then slipped by 22.99% to $325000.0 in 2026.
- Business Quant data shows MRMD's Share-based Compensation at $325000.0 in Q1 2026, $422000.0 in Q4 2025, and $382000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 350,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 350,000.00 |
| Jun 30, 2026 | 350,000.00 |
| Mar 31, 2026 | 325,000.00 |
| Mar 31, 2026 | 325,000.00 |
| Dec 31, 2025 | 422,000.00 |
| Dec 31, 2025 | 422,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | -762,000.00 |
| Dec 31, 2024 | -762,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |